Osteoarthritis affects over 250 million individuals worldwide. Currently, there are no options
for early diagnosis of osteoarthritis, demonstrating the need for biomarker discovery. To find …

Global metabolomic profiling of human synovial fluid for rheumatoid arthritis biomarkers
Page 1 Clinical and Experimental Rheumatology 2019 Clinical and Experimental …

Objective Osteoarthritis (OA) is a multifactorial disease with etiological heterogeneity. The
objective of this study was to classify OA subgroups by generating metabolomic phenotypes …

Purpose Osteoarthritis (OA) is a joint disease that is clinically diagnosed using components
of history, physical exam, and characteristic radiographic findings, such as joint space …

Despite osteoarthritis (OA) and rheumatoid arthritis (RA) being typically age-related, their
underlying etiologies are markedly different. We used 1H nuclear magnetic resonance …

Osteoarthritis (OA) is a progressive, deteriorative disease of articular joints. Although
traditionally viewed as a local pathology, biomarker exploration has shown that systemic …

Currently, reliable biomarkers that can be used to distinguish rheumatoid arthritis (RA) from
other inflammatory diseases are unavailable. To find possible distinctive metabolic patterns …

Osteoarthritis (OA) is a leading cause of chronic joint pain in the older human population.
Diagnosis of OA at an earlier stage may enable the development of new treatments to one …

To identify special metabolites in synovial fluid of osteoarthritis (OA) via a metabolomics
approach. Synovial fluid of 35 participants (25 OA patients and 10 controls) was detected by …

Abstract Purpose of the Review Osteoarthritis (OA) is a multifactorial and progressive
disease affecting whole synovial joint. The extract pathogenic mechanisms and diagnostic …